Skip to Main Content

Paper Details

DNA methylation changes associated with Parkinson's disease progression: outcomes from the first longitudinal genome-wide methylation analysis in blood.
Epigenetics
46
2019
850,000 CpG sites, DNA, PD, Parkinson's Disease, Parkinson's disease, blood, dopamine, dopaminergic, dopaminergic neuronal, epigenome, genomic sites, methylation sites, neurodegeneration, neurodegenerative disorder, patient, patients, whole blood
Author NameAffiliation
Kathleen M Fischc Center for Computational Biology & Bioinformatics, University of California San Diego
Kathleen M Fischc Center for Computational Biology & Bioinformatics, University of California San Diego
Kristen JepsenInstitute for Genomics Medicine , University of California San Diego
Kristen JepsenInstitute for Genomics Medicine , University of California San Diego
Steven D EdlandUniversity of California San Diego
Paula DesplatsUniversity of California San Diego
Paula DesplatsUniversity of California San Diego
  • 1 - 7

Datasets

Release 1.2